Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: As previously disclosed, each of Concentra, the Issuer and Merger Sub III entered into the Merger Agreement, which provides for an Offer by Merger Sub III for all of the Issuer's Common Stock. The Offer commenced on April 15, 2025. On May 15, 2025, the Offer expired and Merger Sub III accepted for purchase a total of 73,398,243 shares tendered and not withdrawn, representing approximately 81.21% of the total shares of the Issuer issued and outstanding. Following the expiration of the Offer, Merger Sub III merged with and into the Issuer on May 15, 2025, pursuant to Section 251(h) of the Delaware General Corporation Law, and, among other things, each share of common stock of Merger Sub III issued and outstanding immediately before the Effective Time automatically converted into the right to receive the Offer Price, with the Issuer surviving as a wholly owned subsidiary of Concentra.